anagrelide hydrochloride monohydrate

Spain

Drugs containing this active substance

  • ANAGRELIDE GLENMARK 0.5 MG HARD CAPSULES EFG

    It is used to treat essential thrombocythemia, a condition in which the bone marrow produces too many platelets, which can cause circulation and clotting problems.

    Form: capsules, hard

    Active substance Dosage
    anagrelide hydrochloride monohydrate 0,61 mg

    ATC: L01X L01XX L01XX35

    Manufacturer: Glenmark Arzneimittel Gmbh

  • ANAGRELIDE PHARMAVÍC 0.5 MG HARD CAPSULES EFG

    It is used to treat patients with essential thrombocythemia, a condition in which the bone marrow produces an excessive number of platelets, which can cause circulation and blood clotting problems.

    Form: capsules, hard

    Active substance Dosage
    anagrelide hydrochloride monohydrate 0,61 mg

    ATC: L01X L01XX L01XX35

    Manufacturer: Pharmavic Iberica S.L.

  • ANAGRELIDE TEVA 0.5 MG HARD CAPSULES EFG

    It is used to treat essential thrombocythemia, a condition in which the bone marrow produces too many platelets, which can cause circulation and clotting problems.

    Form: capsules, hard

    Active substance Dosage
    anagrelide hydrochloride monohydrate 0.61 mg

    ATC: L01X L01XX L01XX35

    Manufacturer: Teva B.V.

  • ANAGRELIDE TEVA-RATIOPHARM 0.5 MG HARD CAPSULES EFG

    It is used to treat patients with essential thrombocythemia, a condition in which the bone marrow produces too many platelets, which can cause circulation and clotting problems.

    Form: capsules, hard

    Active substance Dosage
    anagrelide hydrochloride monohydrate 0,61 mg

    ATC: L01X L01XX L01XX35

    Manufacturer: Teva Pharma S.L.U.